세계의 신약개발 인포매틱스 시장 : 솔루션, 기능, 최종 사용자, 용도별 예측(2025-2030년의)

The Drug Discovery Informatics Market was valued at USD 2.90 billion in 2023, expected to reach USD 3.19 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 5.64 billion by 2030.

Drug Discovery Informatics involves applying computational, statistical, and informational techniques to improve the drug discovery process. The necessity arises from the increasing demand for cost-efficient and accelerated drug development processes, as well as the vast complexity involved in targeting biologically active compounds. Its applications span drug target identification, lead discovery, assay development, and virtual screening. In terms of end-use scope, it finds a place in pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions.

Market growth is significantly influenced by advancements in big data analytics, AI, and machine learning, which enhance predictive accuracy in drug discovery processes. The surge in personalized medicine and rising adoption of cloud-based solutions contribute further to this growth. Opportunities lie in the integration of AI with informatics for precision medicine, collaborative projects to share molecular data, and expanding into emerging markets. Despite these opportunities, challenges include high costs of informatics tools and data management complexities. Rigorous regulations and data privacy concerns also pose hurdles to market expansion.

Innovation can thrive in areas such as developing intuitive user interfaces for data visualization, streamlining data integration across platforms, and enhancing algorithm robustness for better predictive models. Companies should focus on creating scalable solutions that can continuously adapt to the increasing data volume generated in drug discovery. Collaborating with academic institutes and industry players can also facilitate innovation through shared knowledge and resources.

The market is dynamic and competitive, with numerous players contributing to its rapid evolution. Businesses should prioritize staying at the cutting edge of technology trends, fostering interdisciplinary research, and tailoring informatics solutions to specific therapeutic areas to gain a competitive edge. Through a combination of strategic investments and innovative collaborations, companies can effectively navigate the complexities of drug discovery informatics to foster expansion and market success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Informatics Market

The Drug Discovery Informatics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for precision medicine in rare and orphan disease management
  • Favorable government support for drug discovery procedures
  • Rising use of bioinformatic software for drug discovery and development
• Market Restraints
  • Involvement of huge cost for development of bio-informatic infrastructure
• Market Opportunities
  • Potential research investments for the development of drug discovery informatics
  • Integration of next-generation technologies in drug discovery procedures
• Market Challenges
  • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Informatics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Informatics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Informatics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Informatics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Informatics Market

A detailed market share analysis in the Drug Discovery Informatics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Informatics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Informatics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Informatics Market

A strategic analysis of the Drug Discovery Informatics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Informatics Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Agilent Technologies, Inc., Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Cadence Design Systems, Inc., Certara, Inc., Charles River Laboratories International, Inc., ChemAxon Ltd., Cognizant Technology Solutions Corporation, Collaborative Drug Discovery, Inc, Crown Bioscience, Inc., Dassault Systemes SE, Eurofins DiscoverX Products LLC, Evotec AG, Illumina, Inc., Infosys Limited, InSilico Medicine, International Business Machines Corporation, Jubilant Biosys Ltd., Oracle Corporation, PerkinElmer Inc., Schrodinger, Inc., Selvita S.A., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Solutions, market is studied across Services and Software.
• Based on Functions, market is studied across Docking, Libraries & Database Preparation, Molecular Modeling, and Sequencing & Target Data Analysis.
• Based on End-User, market is studied across Contract Research Organizations (CRO) and Pharmaceutical & Biotechnology Companies.
• Based on Application, market is studied across Drug Development and Drug Discovery. The Drug Development is further studied across Clinical Trials and Preclinical Testing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for precision medicine in rare and orphan disease management
    • 5.1.1.2. Favorable government support for drug discovery procedures
    • 5.1.1.3. Rising use of bioinformatic software for drug discovery and development
  • 5.1.2. Restraints
    • 5.1.2.1. Involvement of huge cost for development of bio-informatic infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential research investments for the development of drug discovery informatics
    • 5.1.3.2. Integration of next-generation technologies in drug discovery procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled and experienced professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Discovery Informatics Market, by Solutions

• 6.1. Introduction
• 6.2. Services
• 6.3. Software

7. Drug Discovery Informatics Market, by Functions

• 7.1. Introduction
• 7.2. Docking
• 7.3. Libraries & Database Preparation
• 7.4. Molecular Modeling
• 7.5. Sequencing & Target Data Analysis

8. Drug Discovery Informatics Market, by End-User

• 8.1. Introduction
• 8.2. Contract Research Organizations (CRO)
• 8.3. Pharmaceutical & Biotechnology Companies

9. Drug Discovery Informatics Market, by Application

• 9.1. Introduction
• 9.2. Drug Development
  • 9.2.1. Clinical Trials
  • 9.2.2. Preclinical Testing
• 9.3. Drug Discovery

10. Americas Drug Discovery Informatics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Drug Discovery Informatics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Informatics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accenture PLC
• 2. Agilent Technologies, Inc.
• 3. Aragen Life Sciences Ltd.
• 4. Boehringer Ingelheim International GmbH
• 5. Cadence Design Systems, Inc.
• 6. Certara, Inc.
• 7. Charles River Laboratories International, Inc.
• 8. ChemAxon Ltd.
• 9. Cognizant Technology Solutions Corporation
• 10. Collaborative Drug Discovery, Inc
• 11. Crown Bioscience, Inc.
• 12. Dassault Systemes SE
• 13. Eurofins DiscoverX Products LLC
• 14. Evotec AG
• 15. Illumina, Inc.
• 16. Infosys Limited
• 17. InSilico Medicine
• 18. International Business Machines Corporation
• 19. Jubilant Biosys Ltd.
• 20. Oracle Corporation
• 21. PerkinElmer Inc.
• 22. Schrodinger, Inc.
• 23. Selvita S.A.
• 24. Thermo Fisher Scientific Inc.
• 25. WuXi AppTec Co., Ltd.